美國居民不適用 XM 服務。
R
R

RECSilicon


財經新聞

Italy - Factors to watch on July 9

Italy - Factors to watch on July 9 The following factors could affect Italian markets on Tuesday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy. New items are marked with (*). For a complete list of diary events in Italy please click on IT/DIA . DEBT Treasury to sell up to 8.5 billion euros in bonds at July 11 auction .
A
A
B
E
I
L
P
R
A
I
U

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds Liberty Global, Crest Nicholson, NCR Voyix and Baxter International July 5 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2 000 GMT on Friday: * * Private equity firm Carlyle Group is in exclusive talks to acquire Baxter International's BAX.N kidney care spinoff Vantive for more than $4 billion, including debt, a person familiar with the matter told Reuters.
B
B
B
C
G
H
R
S
T
U
B
T

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds: Thyssenkrupp, Dompe Farmaceutici, Crest Nicholson Updates: BBVA July 5 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Friday: ** Thyssenkrupp TKGA.DE , Salzgitter SZGG.DE and France's Vallourec VLLP.PA are reviewing a sale of their steel joint venture HKM after they were approached by a potential buyer, Germany's largest steelmaker said.
B
B
C
G
H
R
S
T
U
B
T

Italy's Dompe not interested in possible deal with rival drugmaker Recordati

Italy's Dompe not interested in possible deal with rival drugmaker Recordati MILAN, July 5 (Reuters) - Italy's Dompe Farmaceutici is not interested in rival drugmaker Recordati RECI.MI , the biopharmaceutical group's chief executive and chairman said on Friday. "We had looked at it... it is a large company ...we are not on the file," Sergio Dompe told Reuter.
R

Recordati shares rise as investors reportedly circle CVC stake

Recordati shares rise as investors reportedly circle CVC stake MILAN, June 18 (Reuters) - Shares in Italian drugmaker Recordati RECI.MI rose almost 3% on Tuesday, boosted by a report that investment funds KKR KKR.N and TPG TPG.O had expressed preliminary interest in buying a stake in the company. Speculation about the future of Recordati has increased after majority shareholder CVC Capital Partners CVC.AS hired investment banks JP Morgan and Goldman Sachs to explore options for the pharmaceutica
R

Recordati rises after media report on KKR, TPG interest

BUZZ-Recordati rises after media report on KKR, TPG interest ** Shares in Recordati RECI.MI rise as much as 3% after Bloomberg News reported that KKR KKR.N and TPG TPG.O expressed interest in buying a stake in the Italian drugmaker ** The two investment funds, pharma company Angelini Pharma and an Abu Dhabi sovereign fund are among suitors for part or all of the 51.8% stake owned by CVC Capital Partners, Bloomberg News said on Monday, citing people familiar with the matter ** CVC declined to com
R

Italy - Factors to watch on June 18

Italy - Factors to watch on June 18 The following factors could affect Italian markets on Tuesday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy. New items are marked with (*). For a complete list of diary events in Italy please click on IT/DIA . COMPANIES UNICREDIT CRDI.MI The bank said on Monday it was "well above " MREL requirements set by the Single Resolution Board (SRB) and the Bank of Italy, with MREL eligible liabilities equal to 32.8% of risk-weighe
A
E
I
I
L
L
M
R
U
A
B
B
F
I
U

KKR, TPG express interest in Italian drugmaker Recordati - Bloomberg News

MEDIA-KKR, TPG express interest in Italian drugmaker Recordati - Bloomberg News -- Source link: https://tinyurl.com/28c759fu -- Note: Reuters has not verified this story and does not vouch for its accuracy
R

Eiffage, Quilter, Ricardo

EUROPE RESEARCH ROUNDUP-Eiffage, Quilter, Ricardo June 3 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Eiffage, Quilter and Ricardo, on Monday. HIGHLIGHTS * Acciona Energia ANE.MC : Morgan Stanley raises to equalweight from underweight * Eiffage FOUG.PA : Goldman Sachs raises to buy from neutral * Quilter Plc QLT.L : JP Morgan raises to overweight from neutral * Ricardo Plc RCDO.L : Berenberg raises to buy from hold * St.
B
C
C
E
H
H
I
I
J
P
P
R
S
V
D
L
N

Carlsberg, Danske Bank, Teleperformance

EUROPE RESEARCH ROUNDUP- Carlsberg, Danske Bank, Teleperformance May 10 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Carlsberg, Danske Bank and Teleperformance, on Friday. HIGHLIGHTS * Carlsberg A/S CARLB.CO : HSBC raises target price to DKK 1040 from DKK 1030 * Danske Bank DANSKE.CO : HSBC cuts target price to DKK 231 from DKK 238 * Hermes HRMS.PA : Jefferies initiates coverage with buy rating; price target EUR 2,650 * Rathbone
3
A
A
A
B
B
B
B
B
C
C
C
C
D
F
G
G
H
I
K
L
M
P
P
R
S
S
S
T
V
W
Z
A
D
S
S

Italy's Recordati CEO: shareholder CVC committed to company long-term growth

BRIEF-Italy's Recordati CEO: shareholder CVC committed to company long-term growth May 9 (Reuters) - Recordati CEO Rob Koremans tells analysts: CVC, AS A SHAREHOLDER, IS VERY COMMITTED TO THE COMPANY'S LONG-TERM GROWTH M&A IS AN IMPORTANT PART OF OUR STRATEGY, VERY HAPPY IF THE NEXT DEAL COULD BE IN RARE DESEASE BUSINESS Further company coverage: R
R

Italy's Recordati confirms guidance after robust Q1 performance

Italy's Recordati confirms guidance after robust Q1 performance May 9 (Reuters) - Italian drug maker Recordati RECI.MI posted a 10.5% rise in its first-quarter core profit on Thursday and confirmed its guidance for 2024 and 2025. The company said it had seen a "robust performance... across all key geographies and products". Interest, taxes, depreciation and amortisation (EBITDA) rose to 244.0 million euros ($262 million) with a margin of 40.2% for the January-March quarter, the Milan-based compa
R

Recordati Q1 EBITDA Up To EUR 244.0 Mln

BRIEF-Recordati Q1 EBITDA Up To EUR 244.0 Mln May 9 (Reuters) - Recordati Industria Chimica e Farmaceutica SpA RECI.MI : Q1 EBITDA EUR 244.0 MILLION VERSUS EUR 220.8 MILLION YEAR AGO CONFIRMS GUIDANCE FOR 2024 AND 2025 Q1 ADJUSTED NET PROFIT EUR 163.7 MILLION VERSUS EUR 155.0 MILLION YEAR AGO Further company coverage: RECI.MI Reporting by Gdansk Ne
R

Italy - Factors to watch on May 9

Italy - Factors to watch on May 9 The following factors could affect Italian markets on Thursday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy. New items are marked with (*). For a complete list of diary events in Italy please click on IT/DIA . DEBT Treasury sells 7.5 billion euros 12-month BOT bills. Subscriptions close at 0900 GMT.
A
B
E
I
I
L
L
P
R
S
S
T
U
A
B
B
B
B
D
F
P
T
I
U

CVC picks banks to explore options for Italy's pharma group Recordati - sources

CVC picks banks to explore options for Italy's pharma group Recordati - sources MILAN, May 8 (Reuters) - CVC Capital Partners has hired JP Morgan and Goldman Sachs to explore options for Italian pharmaceutical group Recordati RECI.MI , two sources close to the matter said on Wednesday. The private equity firm, which owns a majority stake in Recordati, is considering all options, including a sale, a merger with another healthcare company or the creation of a so-called continuation fund, the sourc
G
R

Italy - Factors to watch on May 7

Italy - Factors to watch on May 7 The following factors could affect Italian markets on Tuesday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy. New items are marked with (*). For a complete list of diary events in Italy please click on IT/DIA . POLITICS Italy's rightwing coalition on Monday passed rules curbing the installation of solar panels on agricultural land , ministers said, in a move that triggered criticism as it could undermine Rome's decarbonisati
F
I
L
L
R
S
U
A
A
B
M
T
I
U

Italy - Factors to watch on April 24

Italy - Factors to watch on April 24 The following factors could affect Italian markets on Wednesday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy. New items are marked with (*). For a complete list of diary events in Italy please click on IT/DIA . POLITICS Italy's Senate gave final approval on Tuesday to a contested government plan to allow groups who "support motherhood" into abortion clinics to try to deter women from terminating pregnancies.
A
A
E
E
F
M
R
U
A
A
D
I
J
S
T
I
U

CVC explores options for Italy's Recordati, Bloomberg News reports

UPDATE 1-CVC explores options for Italy's Recordati, Bloomberg News reports Adds details and background from paragraph 2 onwards April 23 (Reuters) - CVC Capital Partners is exploring options for its controlling stake in Italian pharmaceutical group Recordati SpA RECI.MI , Bloomberg News reported on Tuesday, citing people familiar with the matter.
R

CVC explores options for Italy's Recordati, Bloomberg News reports

CVC explores options for Italy's Recordati, Bloomberg News reports April 23 (Reuters) - CVC Capital Partners is exploring options for its controlling stake in Italian drugmaker Recordati SpA RECI.MI , Bloomberg News reported on Tuesday, citing people familiar with the matter. Reporting by Gnaneshwar Rajan in Bengaluru; Editing by Shilpi Majumdar
R

Cvc Explores Options For €11 Billion Drugmaker Recordati - Bloomberg News

BRIEF-Cvc Explores Options For €11 Billion Drugmaker Recordati - Bloomberg News April 23 (Reuters) - CVC EXPLORES OPTIONS FOR €11 BILLION DRUGMAKER RECORDATI - BLOOMBERG NEWS Source text for Eikon: https://tinyurl.com/khdn87uv Further company coverage: RECI.MI
R



細節

熱門資產

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明